| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,813 | 14,233 | 13,671 | 18,015 | | Cost of Revenue |
-
|
-
|
-
| (25,773) | | | Gross Profit | 16,813 | 14,233 | 13,671 | 43,788 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,136 | 7,956 | 8,493 | 28,690 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,677 | 6,277 | 5,178 | 15,098 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 696 | 3,340 | (2,280) | (5,224) | | Earnings Before Interest And Taxes | 10,604 | 9,617 | 2,898 | 9,874 | | Interest Expense | 376 | 405 | 450 | 548 | | Income Before Tax | 10,228 | 9,212 | 2,448 | 9,326 | | Income Tax Expense | (2,041) | (64) | (274) | 718 | | Minority Interest |
-
|
-
|
-
| (5,195) | | | | Net Income From Continuing Ops | (9,262) | 9,276 | 2,722 | 3,413 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,262) | 9,276 | 2,722 | 3,413 | | Preferred Stock And Other Adjustments | 10,695 | (8,455) | (2,240) |
-
| | | Net Income Applicable To Common Shares | $1,433 | $821 | $482 | $3,413 |
|
0.51% Nasdaq 
Income Statement
